… ) for its Abbreviated New Drug Application (ANDA) Dasatinib Tablets … are indicated for the treatment of adult patients with: … to prior therapy including imatinib, (iii) Philadelphia chromosome … USFDA. Shares of Alembic Pharmaceuticals Limited was last trading …

… FDA has issued final approval for an abbreviated new drug … Pharmaceuticals.1 Dasatinib tablets are currently indicated for the treatment … prior therapy, including imatinib (Gleevec) Adult patients … randomized phase 3 DASISION trial (NCT00481247) randomly …

… FDA has granted final approval to an abbreviated new drug … therapy, including imatinib (Gleevec). for the treatment of adult … phase 2 CA180-372 trial (NCT01460160), which demonstrated … weight. References Alembic Pharmaceuticals Limited announces USFDA Final …

… & Drug Administration (FDA) for its Abbreviated New Drug Application … are indicated for the treatment of adult patients with … to prior therapy including imatinib, (iii) Philadelphia … approvals) from US FDA.   Alembic Pharmaceuticals Limited, a vertically …

… are indicated for the treatment of adult patients with … to prior therapy including imatinib, (iii) Philadelphia chromosome … USFDA nod for anticonvulsant drug Carbamazepine Extended Release … in India, Alembic Pharmaceuticals Limited is a vertically …

… for the abbreviated new drug application (ANDA) of … are indicated for the treatment of adult patients with … to prior therapy including imatinib; and Philadelphia chromosome-positive … Citing IQVIA data, Alembic Pharmaceuticals said Dasatinib tablets, 20 …

… ) for its Abbreviated New Drug Application (ANDA) for Dasatinib … is indicated for the treatment of Philadelphia chromosome-positive … prior therapy such as imatinib. It is also approved … and marketers of generic pharmaceuticals worldwide. Disclaimer: The …

… BFR14 trial (NCT00367861) shared at the 2025 European Society of Medical Oncology … tumors treated with imatinib. The trial’s design compared imatinib interruption to its … standard first-line treatment for advanced GIST with imatinib-sensitive mutations, though …

… for Population Sciences, Harvard Medical School, Venkataraman shared insights … Yes! There are two trials that I think are probably … with Gleevec (imatinib) as the first-line treatment. But oftentimes, … of a large multicenter trial looking at Sutent versus …

… Medical School. Can you discuss emerging second- and third-line treatment … part of a large multicenter trial looking at Sutent (sunitinib … 1 trials looking at the combination of Gleevec (imatinib) and … are also in clinical trial. Transcript has been edited …